Mumbai: US-returned man tests positive for Omicron; Had taken three doses of vaccine
PTI, Dec 18, 2021, 9:35 AM IST
Mumbai: A 29-year-old man who had returned from New York tested positive for Omicron variant here on Friday, the Brihanmumbai Municipal Corporation (BMC) said in a release.
Notably, the man, who has no symptoms, had taken three doses of Pfizer’s coronavirus vaccine, it added.
He tested positive for COVID-19 in a test conducted at the airport on November 9, after which his samples were sent for genome sequencing.
Two of his high-risk contacts tested negative for coronavirus, the BMC said.
”The patient has been admitted to a hospital as a precautionary measure and he has no symptoms,” the civic body said in a release.
This raised the tally of Omicron patients found in the country’s financial capital to 15, including five who are from outside Mumbai.
But 13 of these patients have already been discharged from hospitals.
In fact, none of the 15 Omicron patients found in the city so far has reported severe symptoms, the BMC said.
The tally of Omicron patients in Maharashtra has reached 40.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Over 400 flights delayed at Delhi airport due to bad weather
No link between Sanatana Dharma and Chaturvarnya caste system, says Sivagiri Mutt head
RSS’ lathi-training instills bravery, not meant for public display or fighting: Bhagwat
UPSC seeks details from 2 visually-impaired candidates,who took 2008 civil services, for appointment
BJP destroying future of youths in country: Rahul
MUST WATCH
Latest Additions
Over 400 flights delayed at Delhi airport due to bad weather
No link between Sanatana Dharma and Chaturvarnya caste system, says Sivagiri Mutt head
RSS’ lathi-training instills bravery, not meant for public display or fighting: Bhagwat
UPSC seeks details from 2 visually-impaired candidates,who took 2008 civil services, for appointment
BJP destroying future of youths in country: Rahul
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.